What is NRX Pharmaceuticals, Inc. Common Stock's Market Cap?

NRX Pharmaceuticals, Inc. Common Stock's Market Cap is $153.0M, based on as-reported figures from SEC (XBRL) filings.

What is NRX Pharmaceuticals, Inc. Common Stock's Price / Sales?

NRX Pharmaceuticals, Inc. Common Stock's Price / Sales is 45.1×, based on as-reported figures from SEC (XBRL) filings.

What is NRX Pharmaceuticals, Inc. Common Stock's Revenue (TTM)?

NRX Pharmaceuticals, Inc. Common Stock's Revenue (TTM) is $3.4M, based on as-reported figures from SEC (XBRL) filings.

What is NRX Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?

NRX Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$23.5M, based on as-reported figures from SEC (XBRL) filings.

What is NRX Pharmaceuticals, Inc. Common Stock's EBITDA?

NRX Pharmaceuticals, Inc. Common Stock's EBITDA is -$19.7M, based on as-reported figures from SEC (XBRL) filings.

What is NRX Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?

NRX Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -0.54, based on as-reported figures from SEC (XBRL) filings.

What is NRX Pharmaceuticals, Inc. Common Stock's EBITDA Margin?

NRX Pharmaceuticals, Inc. Common Stock's EBITDA Margin is -580.2%, based on as-reported figures from SEC (XBRL) filings.

NRX Pharmaceuticals, Inc. Common Stock (NRXP) Financial Statements

NRX Pharmaceuticals, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00JCWDNX3

XNAS · usd

3.53▲ 0.06 (1.81%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt—

Trading Information

Previous Close3.47

Day's Range3.42 – 3.54

52-Week Range1.62 – 5.06

Volume704.3K

Avg Volume1.0M

Share Statistics

Shares Outstanding

Employees29

ExchangeXNAS

Listed2021-05-25

Share count as of August 14, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about NRX Pharmaceuticals, Inc. Common Stock (NRXP)

What is NRX Pharmaceuticals, Inc. Common Stock's Market Cap?: NRX Pharmaceuticals, Inc. Common Stock's Market Cap is $153.0M, based on as-reported figures from SEC (XBRL) filings.
What is NRX Pharmaceuticals, Inc. Common Stock's Price / Sales?: NRX Pharmaceuticals, Inc. Common Stock's Price / Sales is 45.1×, based on as-reported figures from SEC (XBRL) filings.
What is NRX Pharmaceuticals, Inc. Common Stock's Revenue (TTM)?: NRX Pharmaceuticals, Inc. Common Stock's Revenue (TTM) is $3.4M, based on as-reported figures from SEC (XBRL) filings.
What is NRX Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?: NRX Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$23.5M, based on as-reported figures from SEC (XBRL) filings.
What is NRX Pharmaceuticals, Inc. Common Stock's EBITDA?: NRX Pharmaceuticals, Inc. Common Stock's EBITDA is -$19.7M, based on as-reported figures from SEC (XBRL) filings.
What is NRX Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?: NRX Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -0.54, based on as-reported figures from SEC (XBRL) filings.
What is NRX Pharmaceuticals, Inc. Common Stock's EBITDA Margin?: NRX Pharmaceuticals, Inc. Common Stock's EBITDA Margin is -580.2%, based on as-reported figures from SEC (XBRL) filings.